This article provides a summary of several errata and corrigenda issued in the journal Nature Biotechnology for articles published in 2012. The first erratum, "Reinventing clinical trials," corrects an error in the description of a product used in a clinical trial. The original article mistakenly referred to "Recruit" technology, but it was actually "eDiary," a tool that allows patients to report clinical trial data through mobile phones or internet portals. The text has been revised to reflect this correction, including a description of how patients can respond to questionnaires and receive reminders for delayed responses. Additionally, some text related to "Recruit" was removed due to space constraints, and a note was added about Eric Westin's departure from Lilly Oncology. The second erratum, "Parallel genome universes," corrects a citation error in a reference, changing the volume number and year from 29 and 2011 to 30 and 2012. The third erratum, "BASF moves GM crop research to US," corrects a statement about BASF's Amflora potato, clarifying that it is not blight resistant. The fourth erratum, "In Their Words," corrects an error in identifying Craig Thompson as the president of Rockefeller University, when he is actually the president of Memorial Sloan-Kettering Cancer Center. Finally, two corrigenda correct errors in the accession codes and measurements in articles about genome sequencing platforms.This article provides a summary of several errata and corrigenda issued in the journal Nature Biotechnology for articles published in 2012. The first erratum, "Reinventing clinical trials," corrects an error in the description of a product used in a clinical trial. The original article mistakenly referred to "Recruit" technology, but it was actually "eDiary," a tool that allows patients to report clinical trial data through mobile phones or internet portals. The text has been revised to reflect this correction, including a description of how patients can respond to questionnaires and receive reminders for delayed responses. Additionally, some text related to "Recruit" was removed due to space constraints, and a note was added about Eric Westin's departure from Lilly Oncology. The second erratum, "Parallel genome universes," corrects a citation error in a reference, changing the volume number and year from 29 and 2011 to 30 and 2012. The third erratum, "BASF moves GM crop research to US," corrects a statement about BASF's Amflora potato, clarifying that it is not blight resistant. The fourth erratum, "In Their Words," corrects an error in identifying Craig Thompson as the president of Rockefeller University, when he is actually the president of Memorial Sloan-Kettering Cancer Center. Finally, two corrigenda correct errors in the accession codes and measurements in articles about genome sequencing platforms.